Abstract 2138: ALG01, a next-generation anti-PD-L1×TROP-2 bispecific antibody-drug conjugate (BiADC) with STAR technology, demonstrated excellent anti-tumor efficacy & safety in preclinical studies
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Jun Xiang, Wenlong Gao
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409628810